StockData
Fortrea Holdings Inc. logo

Fortrea Holdings Inc. (FTRE) stock

FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$19.59−0.20 (-1.01%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Fortrea price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Fortrea's price to sales ratio was 0.7× on Nov 11, 2026, against 0.4× a year earlier. Over the last 3 years it ranged from 0.1× to 1.3×, with a median of 0.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×+0.1
2025Dec 31, 20250.6×−0.0
2024Dec 31, 20240.6×−0.6
2023Dec 29, 20231.2×–

More Fortrea figures

See a number that looks wrong?